Skip to main content
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ARMP ISIN · US04216R1023 LEI · 549300QM1VCWH8KT0S21 US Manufacturing
Open in API
Filings indexed 1,011 across all filing types
Latest filing 2006-06-16 Regulatory Filings
Country US United States of America
Listing US ARMP

About Armata Pharmaceuticals, Inc.

https://www.armatapharma.com/

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2006
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content specifically details the approval and granting of stock options to executive officers under a stock option plan, including the number of shares, exercise price, and expiration date. This is an announcement of a material definitive agreement related to executive compensation and stock options. It is not a full annual report, earnings release, or management discussion, but rather a regulatory filing reporting a specific event. Given the nature of the content and the form type, the most appropriate classification is Regulatory Filings (RNS). The document length is short (3162 characters), and it contains substantive information about the event rather than just a notice of report publication or certification. Therefore, the confidence in this classification is high.
2006-06-16 English
FORM 4 SUBMISSION
Director's Dealing
2006-06-13 English
FORM 4 SUBMISSION
Director's Dealing
2006-06-13 English
FORM 4 SUBMISSION
Director's Dealing
2006-06-13 English
Regulatory Filings 2006
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text references an interim data presentation from a Phase I/II trial and includes a press release as an exhibit. The document does not contain comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It is also not a certification, proxy, or voting result announcement. Given the nature of the 8-K and the content focusing on an event announcement and press release, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories. The document length is short (2499 characters), and it is primarily an announcement rather than a full report.
2006-06-02 English
Share Issue/Capital Change 2006
Share Issue/Capital Change Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated May 10, 2006. It reports a material modification to the rights of security holders, specifically a one-for-ten reverse stock split of the company's common stock. It also includes amendments to the articles of incorporation to effect the reverse split and adjust authorized shares. The document includes a press release and amended articles as exhibits. The content focuses on corporate actions related to capital structure changes, specifically a reverse stock split and related amendments. This fits the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues, stock splits, or other capital changes. The document is not a full financial report, earnings release, or management discussion, but a regulatory filing announcing a capital structure change. The length and detail confirm it is the actual announcement, not just a brief notice or report publication announcement. Therefore, the appropriate classification is SHA with high confidence.
2006-05-12 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.